BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15667555)

  • 1. Comparative analysis of patients with clinically diagnosed colorectal cancer and those detected by mass screening.
    Colorectal Cancer Cooperating Group, Beijing Society of Gastroenterology
    Chin J Dig Dis; 2005; 6(1):26-30. PubMed ID: 15667555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
    Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
    Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High uptake of colonoscopy in first-degree relatives of patients with colorectal cancer in a healthcare region: a population-based, prospective study.
    Armelao F; Orlandi PG; Tasini E; Franceschini G; Franch R; Paternolli C; de Pretis G
    Endoscopy; 2010 Jan; 42(1):15-21. PubMed ID: 20066589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and survival rate of elderly patients with colorectal cancer detected by immunochemical occult blood screening.
    Zhang B; Fattah A; Nakama H
    Hepatogastroenterology; 2000; 47(32):414-8. PubMed ID: 10791202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
    Kronborg O; Jørgensen OD; Fenger C; Rasmussen M
    Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
    Zhang YZ; Sheng JQ; Li SR; Wu ZT
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for colorectal cancer with an immunological fecal occult blood test].
    Fernández JL; Gallegos M; Brochero A; Arévalo C; Piccioni H; Gutiérrez Galiana H
    Acta Gastroenterol Latinoam; 1999; 29(2):73-8. PubMed ID: 10491719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first 2 years of colorectal cancer screening in Ferrara, Italy.
    Matarese VG; Feo CV; Lanza G; Fusetti N; Carpanelli MC; Cataldo S; Cifalà V; Ferretti S; Gafà R; Marzola M; Montanari E; Palmonari C; Simone L; Trevisani L; Stockbrugger R; Gullini S
    Eur J Cancer Prev; 2011 May; 20(3):166-8. PubMed ID: 21445018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening practices of patients presenting for resection of a colorectal neoplasm.
    Hedrick TL; Galloway RP; McElearney ST; Smith RL; Ledesma EJ; Wilson WH; Sawyer RG; Friel CM; Foley EF
    Am Surg; 2006 Jan; 72(1):89-95. PubMed ID: 16494194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
    Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
    Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
    Hofbauer F; Mach K; Egermann G
    Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk analyses for screening sigmoidoscopy based on a colorectal cancer (CRC) population.
    Mulder SA; Ouwendijk RJ; Giard RW; Van Leerdam ME; Kuipers EJ
    Scand J Gastroenterol; 2009; 44(2):205-10. PubMed ID: 18836946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer.
    Renkonen-Sinisalo L; Aarnio M; Mecklin JP; Järvinen HJ
    Cancer Detect Prev; 2000; 24(2):137-42. PubMed ID: 10917133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Lohsiriwat V; Thavichaigarn P; Awapittaya B
    J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of screening colonoscopy in a community-based study].
    Hüppe D; Hartmann H; Felten G; Kemen M; Tannapfel A; Gillessen A; Katalinic A
    Z Gastroenterol; 2008 Feb; 46(2):193-200. PubMed ID: 18253898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
    Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
    Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.